• Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML

    Source: Nasdaq GlobeNewswire / 12 Jun 2019 01:00:12   America/Los_Angeles

    N/A
Share on,